Kruse, M.* ; Kemper, M.* ; Gancheva, S.* ; Osterhoff, M.* ; Dannenberger, D.* ; Markgraf, D.* ; Machann, J. ; Hierholzer, J.* ; Roden, M.* ; Pfeiffer, A.F.H.*
Dietary rapeseed oil supplementation reduces hepatic steatosis in obese men-a randomized controlled trial.
Mol. Nutr. Food Res. 64:e2000419 (2020)
Scope Effective treatment for obesity associated non-alcoholic fatty liver disease (NAFLD) is limited. Dietary supplementation of n-3 polyunsaturated fatty acids, specifically alpha linolenic acid (ALA), can resolve intrahepatic lipid content (IHL). This study investigates the effect of daily supplementation of either refined rapeseed (RA), containing high amounts of ALA, or refined olive (OL) oil on IHL and glucose metabolism in NAFLD patients. Methods and results 27 obese men consumed an isocaloric diet including either 50 g of RA or OL daily for 8 weeks. Hepatic proton magnetic resonance spectroscopy, hyperinsulinemic-euglycemic clamp studies and blood tests are performed before and at the end of the study. At 8 weeks a significant reduction in IHL is observed for RA (13.1 +/- 1.6 before versus 11.1 +/- 1.6% after intervention) versus OL (13.3 +/- 2.5 before versus 15.7 +/- 2.7% after intervention). For RA, a 21% reduction (P< 0.02) in serum free fatty acids (FFA) and a 1.68-fold increase (P= 0.03) of serum interleukin-6 (IL-6) is observed after 8 weeks. Conclusion RA has a beneficial effect on hepatic lipid metabolism as shown by reduced IHL and serum FFA. RA induced IL-6 production seems to be liver protective confirming previous results.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Hepatic Steatosis ; Obesity ; Olive Oil ; Rapeseed Oil ; Serum Lipids; Nonalcoholic Fatty Liver; Alpha-linolenic Acid; Insulin-resistance; Adipose-tissue; Metabolic Syndrome; N-6/n-3 Ratio; Disease; Inflammation; Glucose; Risk
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2020
Prepublished im Jahr
HGF-Berichtsjahr
2020
ISSN (print) / ISBN
1613-4125
e-ISSN
1613-4133
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 64,
Heft: 21,
Seiten: ,
Artikelnummer: e2000419
Supplement: ,
Reihe
Verlag
Wiley
Verlagsort
111 River St, Hoboken 07030-5774, Nj Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
90000 - German Center for Diabetes Research
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502400-001
Förderungen
German Federal Ministry of Education and Research
Union zur Forderung von Oel- und Proteinpflanzen e. V., Germany
Copyright
Erfassungsdatum
2020-10-30